Medtronic Diabetes
Discover how I shaped the messaging for Medtronic’s MiniMed 670G system, a groundbreaking healthcare innovation recognized by Time Magazine as one of 2016’s Most Important Inventions.
Introduction
Take a look into an in-depth take at my work with Medtronic Diabetes, where I contributed to the launch of the groundbreaking MiniMed 670G system—the world’s first hybrid closed-loop insulin delivery system. This project was a blend of strategic storytelling and patient-focused marketing that aimed to redefine life for individuals with Type 1 diabetes.
Challenge
The challenge was introducing a highly technical product, the MiniMed 670G, to a broad audience in a way that balanced its innovative features with its life-changing benefits. The goal was to create messaging that was not only scientifically accurate but also accessible, empowering, and resonant with patients and healthcare providers alike.
Solution
To address this challenge, I collaborated with cross-functional teams to develop a compelling brand narrative that highlighted the MiniMed 670G’s transformative potential. Key contributions included:
Crafting patient-centric messaging that emphasized the system’s ability to simplify diabetes management and improve quality of life.
Developing campaign materials to communicate the 670G’s groundbreaking features in a relatable, easy-to-understand way.
Showcasing the system’s innovation through content that earned recognition from major media outlets, including being named one of Time Magazine's Most Important Inventions of 2016.
Conclusion
The MiniMed 670G system launch was a milestone project that demonstrated the power of effective storytelling in healthcare marketing. By translating complex technology into meaningful messaging, I helped Medtronic Diabetes elevate the product’s visibility and impact, earning global recognition and changing lives.